|
Dr. Ashok K. Srivastava - Bibliography (Last Five Years)
| Papers |
- Srivastava, A.K.: Hyperglycemia-induced
protein kinase signaling pathways in vascular smooth muscle
cells: implications in the pathogenesis of vascular dysfunction
in diabetes. Adv. Exp. Med. Biol. 498: 311-318, 2001.
- Tardif, A., Julien, N., Pelletier, A., Thibault, G., Srivastava,
A.K., Chiasson, J.-L., and Coderre, L. : Chronic
exposure to x-hydroxybutyrate impairs insulin action in
primary cultures of adult cardiomyocytes. Am. J. Physiol.
Endocrinol. Metab. 281: E1205-E1212, 2001.
- Srivastava, A.K.: High-glucose-induced
activation of protein kinase signaling pathway in vascular
smooth muscle cells: A potential role in the pathogenesis
of vascular dysfunciton in diabetes. Intl. J. Mol. Medicine
9: 85-89, 2002.
- Blanc, A., Pandey, N.R., and Srivastava, A.K.:
Synchronous activation of ERK ½, p38mapk and PKB/Akt
signaling by H2O2 in vascular smooth
muscle cells: potential involvement in vascular disease.
Intl. J. Mol. Medicine 11: 229-234, 2003.
- Théberge, J.-F., Mehdi, M.Z., Pandey, S.K., and
Srivastava, A.K.: Prolongation of insulin-induced
activation of mitogen-activated protein kinases ERK ½
and phosphatidylinositol 3-kinase by vanadyl sulfate, a
protein tyrosine phosphatase inhibitor. Arch. Biochem. Biophys.
420: 9-17, 2003.
- Blanc, A., Pandey, N.R., and Srivastava, A.K.:
Distinct Roles of Ca2+, calmodulin and protein
kinase C in H2O2 - induced activation of ERK 1/2, p38MAPK
and protein kinase B in vascular smooth muscle cells. Antioxidants
and Redox Signaling 6: 353-366, 2004.
- Bou Dao, G., and Srivastava, A.K.: Reactive
oxygen species mediate of endothelin-induced activation
of PYK-2, ERK ½, PKB/Akt and protein synthesis
in vascular smooth muscle cells. Free Radical Biology and
Medicine 37: 208-215, 2004.
- Coderre, L., and Srivastava, A.K.: Vanadium
and the cardiovascular system. Can. J. Physiol. Pharmacol.
82: 833-839, 2004.
- Srivastava, A.K., Mehdi, M.Z.: Insulin-mimetic
and antidiabetic effects of vanadium compounds. Diabetic
Med. 22: 2-13, 2005.
- Mehdi, M.Z., Pandey, N.R., Pandey, S.K., and Srivastava,
A.K.: H2O2-induced phosphorylation
of ERK ½ and PKB requires tyrosine kinase activity
of insulin receptor and c-Src. Antioxidant and Redox Signaling
7: 1014-1020, 2005.
- Srivastava, A.K.: Redox regulation of
insulin action and signaling. Antioxidant and Redox Signaling
7: 1011-1013, 2005.
- Mehdi, M.Z., and Srivastava, A.K.: Organo-0vanadium
compounds are potent activators of protein kinase B signaling
pathway of protein tyrosine phosphorylation: Mechanism of
insulinimimesis. Arch. Biochem. Biophys. 440: 158-164,
2005.
- Mehdi, M.Z., Pandey, S.K., Théberge, J.-F., and
Srivastava, A.K.: Insulin
signal mimicry as a mechanism for insulin-like effects of
vanadium. Cell Biochem. Biophys. 44 : 73-82, 2006
- Azar, Z.M., Mehdi, M. Z. and Srivastava, A. K.:
Activation of insulin-like growth
factor type-1 receptor is required for H2O2-
induced PKB phosphorylation in vascular smooth cells.
Can. J. Physiol. Pharmacol. 84:777-786, 2006
- Mehdi, M.Z., Verdatsikos, G.,Pandey, S.K. and Srivastava,
A.K.: Involvement of insulin -like growth
factor receptor and protein kinase C -delta in Bis(maltolato)-oxovanadium
(IV) -induced phosphorylation of PKB in HepG2 cells.
Biochemistry (In Press).
- Mehdi, M. Z. Azar, Z.M. and Srivastava, A. K.:
Role of receptor and non-receptor PTKs in H2O2-
induced ERK ½ and PKB signaling. Cell Biochem. and
Biophys. (In Press )
- Bouallague, A.,Bou Daou, G. and Srivastava, A.
K.: Endothelin-1- induced signaling pathways in
vascular smooth muscle cells. Curr. Vascular Pharmacol.
(In Press )
|
| Book Chapters |
- Théberge, J.-F., Pandey, S.K., and Srivastava,
A.K.: The protein tyrosine phosphatase inhibitor
vanadyl sulfate prolongs insulin-induced activation of mitogen-activated
protein kinases ERK 1 and ERK 2 as well as phosphatidylinositol
3-kinase. In: Pharmacology and Therapeutics in the New Millenium,
Gupta, S.K., Ed., Narosa Publishing House, 2001, New Delhi,
India, pp. 726-738, 2000
- Srivastava, A.K.: Hyperglycemia-induced
protein kinase signaling pathways in vascular smooth muscle
cells: Implications in the pathogenesis of vascular dysfunction
in diabetes. In: Diabetes and Cardiovascular Disease: Proceedings
of an international conference. Angel, A., Singal, P.K.,
Pierce, G., and Dhalla, N.S., Eds., Kluwer Academic Plenum
Publishers, Boston, USA ,pp. 311-318, 2001.
- Srivastava, A.K., Pandey, N.R., and Blanc,
A.: Activation of mitogen-activated protein kinases and
protein kinase B/Akt signaling by oxidative stress in vascular
smooth muscle cells: involvement in vascular pathophysiology.
In: Pathophysiology of Cardiovascular Disease, Dhalla, N.-S.,
Rupp, H., Angel, A. and Pierce G.N.. Eds., Kluwer Academic
Publications, Boston, USA pp. 405-416, 2004.
- Srivastava, A.K.: Insulino-mimetic actions of vanadium
compounds in cardiovascular system. In: Antioxidants and
Cardiovascular Disease, Nath, N., Khullar, M., and Singal,
P.K., Eds., Narosa Publishing House., New Delhi, India,
pp. 203-210, 2004.
- Mehdi, M.Z., and Srivastava, A.K.: Cell-specific
effects of diphenyleneiodonium (DPI) on insulin-induced
signaling events. In: Second Messenger and Phosphoprotein
Signaling: Proceedings of the 12th International
Conference on Second Messengers and Phosphoproteins. Anand-Srivastava,
M.B.,Tremblay, M. and Srivastava, A.K., Eds., Monduzzi Editor,
Medimond International Proceedings Division, Bologna, Italy
, pp. 143-148, 2004.
- Chiasson, J.-L, Rabasa-Lhoret, R., and Srivastava,
A.K.: Oxidative stress in the development of diabetes
and its complications. In: Antioxidants and Cardiovascular
Disease, Tardif, J.C., Bourassa, M.G., Eds. Springer, New
York, pp.380-391, 2006.
|
| Books |
- Anand-Srivastava, M.B., Tremblay, M., and Srivastava,
A.K. Second Messengers and Phosphoprotein Signaling,
Monduzzi Editore, Medimond International Proceedings Division,
Bologna, Italy, pp.1-243, 2004
|
|